Eagle Wealth Strategies’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,000
Closed -$508K 118
2025
Q4
$508K Hold
5,000
0.24% 46
2025
Q3
$274K Hold
5,000
0.14% 82
2025
Q2
$266K Hold
5,000
0.15% 81
2025
Q1
$216K Hold
5,000
0.13% 83
2024
Q4
$281K Buy
5,000
+1,000
+25% +$62.2K 0.2% 76
2024
Q3
$272K Buy
+4,000
New +$226K 0.2% 84
2024
Q2
Sell
-4,000
Closed -$282K 93
2024
Q1
$282K Hold
4,000
0.23% 72
2023
Q4
$296K Buy
+4,000
New +$262K 0.18% 69

Other funds holding EXAS

Eagle Wealth Strategies's EXAS Position: Q1 2026 in Review

Eagle Wealth Strategies sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,000 shares — an estimated $508K sold.

Eagle Wealth Strategies first reported a position in EXAS in Q4 2023 and held it in 8 quarters. The position peaked at $508K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Eagle Wealth Strategies reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Eagle Wealth Strategies sold 5,000 Exact Sciences shares in Q1 2026, an estimated $508K.
  • Eagle Wealth Strategies first reported a position in Exact Sciences in Q4 2023 and held it in 8 quarters.
  • Eagle Wealth Strategies's Exact Sciences position peaked at $508K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Eagle Wealth Strategies's 13F filing for Q1 2026, filed 10 Apr 2026.